Tianjin Ringpu Bio-Technology Co.,Ltd. (300119.SZ)
CNY 19.22
(0.26%)
CNY 19.22
(0.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 378.19 Million | 389.48 Million | 382.62 Million | 388.43 Million | 383.6 Million | 174.88 Million |
| Net Income | 511.01 Million | 373.76 Million | 433.58 Million | 439.49 Million | 223.79 Million | 141.04 Million |
| Depreciation & Amortization | 144.47 Million | 115.56 Million | 91.56 Million | 95.74 Million | 91.28 Million | 91.75 Million |
| Deferred income taxes | 21.98 Million | 3.48 Million | 19.59 Million | 22.58 Million | 4.31 Million | -2.74 Million |
| Stock-based compensation | 6.33 Million | 4.37 Million | 5.95 Million | 16.75 Million | 12.56 Million | - |
| Change in working capital | -148.55 Million | -95.59 Million | -85.29 Million | -132.02 Million | 51.32 Million | -81.83 Million |
| Other non-cash items | -128.74 Million | -4.25 Million | -57.22 Million | -14.77 Million | 17.2 Million | 23.91 Million |
| Investing Cash Flow | -160.97 Million | -1.24 Billion | -627.06 Million | -243.07 Million | -397.76 Million | -145.41 Million |
| Investments in PPE | -244.48 Million | -372.43 Million | -305.87 Million | -259.16 Million | -229.7 Million | -112.44 Million |
| Acquisitions | 159.72 Million | 110.91 Thousand | 12.82 Million | 168.63 Thousand | 231.01 Million | 68.79 Thousand |
| Investment purchases | -3.73 Billion | -3.39 Billion | -1.23 Billion | -913.14 Million | -1.35 Billion | -1.71 Billion |
| Sales/Maturities of investments | 3.65 Billion | 2.5 Billion | 900.39 Million | 911.72 Million | 1.18 Billion | 1.68 Billion |
| Other Investing Activities | 212.01 Thousand | 16.93 Million | 1.49 Million | 17.35 Million | -229.7 Million | -446.25 Thousand |
| Financing Cash Flow | -272.46 Million | -48.34 Million | 1.26 Billion | -169.85 Million | 92.63 Million | -125.93 Million |
| Debt repayment | -716.49 Million | -838.33 Million | -126.56 Million | -798 Million | -354.63 Million | -408.35 Million |
| Dividends payments | -139.2 Million | -163.69 Million | -160.08 Million | -100.05 Million | -60.67 Million | -80.27 Million |
| Common Stock Repurchased | -44.92 Million | -1.78 Million | - | -915.9 Thousand | -100.49 Million | - |
| Common Stock Issuance | - | 1.78 Million | -4.05 Million | 915.9 Thousand | 100.49 Million | - |
| Other Financing Activities | -85.08 Million | 980.39 Million | 1.31 Billion | 743.52 Million | 534.78 Million | 362.69 Million |
| Accounts receivables | -186.75 Million | -180.5 Million | -178.29 Million | -101.74 Million | 26.8 Million | -124.53 Million |
| Accounts payables | 38.5 Million | 87.53 Million | 70.71 Million | 47.95 Million | 26.17 Million | 67.02 Million |
| Inventory | -22.29 Million | -6.11 Million | 2.68 Million | -100.81 Million | -5.97 Million | -21.56 Million |
| Other working capital | 21.98 Million | 3.48 Million | 19.59 Million | 22.58 Million | 4.31 Million | -60.26 Million |
| Cash at beginning of period | 376.7 Million | 1.28 Billion | 264.36 Million | 288.85 Million | 210.37 Million | 306.83 Million |
| Cash at end of period | 321.52 Million | 376.7 Million | 1.28 Billion | 264.36 Million | 288.85 Million | 210.37 Million |
| Capital Expenditure | -244.48 Million | -372.43 Million | -305.87 Million | -259.16 Million | -229.7 Million | -112.44 Million |
| Effect of forex changes on cash | 64.25 Thousand | 44.01 Thousand | -0.01 | -0.22 | 0.04 | -0.04 |
| Net cash flow / Change in cash | -55.17 Million | -903.54 Million | 1.01 Billion | -24.48 Million | 78.47 Million | -96.46 Million |
| Free Cash Flow | 133.71 Million | 17.05 Million | 76.75 Million | 129.27 Million | 153.9 Million | 62.43 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 85.59 Million | 71.56 Million | 87.57 Million | 179.24 Million | 511.01 Million | 95.42 Million |
| Depreciation & Amortization | - | 45.03 Million | 45.03 Million | 37.29 Million | 144.47 Million | 37.29 Million |
| Deferred income taxes | - | - | - | 191.48 Million | 21.98 Million | -102.61 Million |
| Stock-based compensation | - | - | - | 6.33 Million | 6.33 Million | -2.1 Million |
| Change in working capital | - | - | - | -197.82 Million | -148.55 Million | 104.72 Million |
| Other non-cash items | 79.68 Million | 82.27 Million | 13.16 Million | -35.31 Million | -128.74 Million | -66.48 Million |
| Investing Cash Flow | -304.37 Million | -103.69 Million | 174.73 Million | -320.34 Million | -160.97 Million | 155.59 Million |
| Investments in PPE | -27.95 Million | -63.25 Million | -54.05 Million | -65.7 Million | -244.48 Million | -68.1 Million |
| Acquisitions | 40.17 Thousand | -202.64 Million | 5150.00 | 0.34 | 159.72 Million | 82.64 Million |
| Investment purchases | -843.54 Million | -863.85 Million | -779.5 Million | -1.31 Billion | -3.73 Billion | -588.57 Million |
| Sales/Maturities of investments | 565.55 Million | 1.02 Billion | 973.28 Million | 981.31 Million | 3.65 Billion | 732.63 Million |
| Other Investing Activities | 1.56 Million | 185.38 Thousand | 35 Million | 79.76 Million | 212.01 Thousand | -3 Million |
| Financing Cash Flow | 101.55 Million | -242.94 Million | 15.98 Million | 78.23 Million | -272.46 Million | -115.51 Million |
| Debt repayment | -373.89 Million | -10.65 Million | -43.4 Million | -77.5 Million | -716.49 Million | -125.88 Million |
| Dividends payments | -5.69 Million | -192.61 Million | -8.27 Million | -139.2 Million | -139.2 Million | -4.49 Million |
| Common Stock Repurchased | 15.07 Million | -15.07 Million | - | -44.92 Million | -44.92 Million | 15.11 Million |
| Common Stock Issuance | - | - | - | - | - | -15.11 Million |
| Other Financing Activities | -266.63 Million | -212.62 Million | -19.13 Million | -58.66 Million | -85.08 Million | 14.87 Million |
| Accounts receivables | - | - | - | -186.75 Million | -186.75 Million | 71.83 Million |
| Accounts payables | - | - | - | - | 38.5 Million | - |
| Inventory | - | - | - | -22.29 Million | -22.29 Million | 36.11 Million |
| Other working capital | - | - | - | 11.22 Million | 21.98 Million | -3.22 Million |
| Cash at beginning of period | 378.91 Million | 617.35 Million | 321.52 Million | 382.39 Million | 376.7 Million | 282.09 Million |
| Cash at end of period | 336.42 Million | 387.17 Million | 601.44 Million | 321.52 Million | 321.52 Million | 382.39 Million |
| Capital Expenditure | -27.95 Million | -63.25 Million | -54.05 Million | -65.7 Million | -244.48 Million | -68.1 Million |
| Effect of forex changes on cash | 36.68 Thousand | 295.79 Thousand | 59.67 Thousand | 9444.19 | 64.25 Thousand | 11.96 Thousand |
| Net cash flow / Change in cash | -42.49 Million | -230.17 Million | 279.91 Million | -60.86 Million | -55.17 Million | 100.3 Million |
| Free Cash Flow | 137.32 Million | 45.55 Million | 46.68 Million | 115.52 Million | 133.71 Million | -1.86 Million |
AWR
601628
600722
600569
GSS
VEON